ONCE bitten, twice shy. After suffering huge weather-related losses as a result of climate change, the insurance industry has turned its attention to the possible risks posed by nanotechnology.
On 10 May, the global reinsurance company Swiss Re published its findings on potential hazards of nanoparticles, specks of material no more than 100 nanometres across.
Such particles are being manufactured in bulk for novel materials, for use in cosmetics and for experimental drugs. The report draws on more than 100 scientific papers to reveal that these tiny particles can pass unhindered into the human body and float freely through the…
